Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD — Stella

Home/Glomerulonephritis, IGA/Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

View on ClinicalTrials.gov

Recruiting

Back to Glomerulonephritis, IGA trials

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

AFMMU, Xi'an

Key details

Phase

Large-scale testing

Sponsor

Air Force Military Medical University, China

Enrollment target

~208 participants

Started

February 2024

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.